Apixaban API has been approved by China NMPA
One step further with Apixaban. We are happy to announce that Apixaban API has been approved by China NMPA.
🎉🎉 This is a significant milestone for our company. Really great job from our regulatory, intellectual property, manufacturing and business development departments based in Malta, Spain and China!